The Changing Face of Fungal Infections in Health Care Settings

As strategies to prevent invasive fungal infections among both hospitalized and nonhospitalized patients have evolved, the epidemiology of these infections has changed. Several unique features of select Candida species and molds have facilitated the emergence of these pathogens as more-common causes...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2005-11, Vol.41 (10), p.1455-1460
Main Authors: Weinstein, Robert A., Fridkin, Scott K.
Format: Article
Language:English
Subjects:
Antifungal Agents - therapeutic use
Antifungals
Aspergillosis
Biological and medical sciences
Candida
Candidemia
Communicable Diseases, Emerging - epidemiology
Communicable Diseases, Emerging - microbiology
Cross Infection - drug therapy
Cross Infection - epidemiology
Cross Infection - microbiology
Epidemiology
Fungal infections
Fungemia - drug therapy
Fungemia - epidemiology
Fungemia - microbiology
Fungi
Health care
Healthcare Epidemiology
Hematopoietic stem cells
Humans
Incidence
Infections
Infectious diseases
Medical sciences
Medical treatment
Mortality
Mycoses - drug therapy
Mycoses - epidemiology
Mycoses - microbiology
Risk Factors
Transplantation
Zygomycosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As strategies to prevent invasive fungal infections among both hospitalized and nonhospitalized patients have evolved, the epidemiology of these infections has changed. Several unique features of select Candida species and molds have facilitated the emergence of these pathogens as more-common causes of infection than in previous years. In this context, the changing pathogen profiles, unique antifungal susceptibilities, and approaches to treatment are outlined.
ISSN:1058-4838
1537-6591
DOI:10.1086/497138